Monitoring the impact of regulatory measures on medicine pricing in Thailand: an observation over a 16-year span.
Date
2025Author
Sooksriwong, ChaoncinHirunrassamee, Sanita
Suwattanapreeda, Siriwat
Maluangnon, Kusawadee
Chuachantra, Thirapich
Babar, Zaheer-Ud-Din
Kuchaisit, Krissana
Osirisakul, Niti
...show more authors ...show less authors
Metadata
Show full item recordAbstract
Following a 2007 report by the Thai Food and Drug Administration highlighting disparities in drug pricing across different sectors, there has been a concerted effort to establish and enforce a cohesive medicine pricing policy in Thailand. This study aims to explore the government interventions on medicine pricing in Thailand. Employing a mixed-methods approach, this research included a literature review and a cross-sectional survey of medicine prices using the World Health Organization/Health Action International (WHO/HAI) methodology. Data were collected from both public and private sectors across six provinces in Thailand during April-May 2023. Additionally, international price comparisons were conducted with countries including Australia, Canada, Denmark, Malaysia, and New Zealand. The research identified a significant reduction in the median price ratios (MPRs) of medicines, closer alignment of prices with international benchmarks, and decreased variability in pricing between regions and sectors. These changes illustrated the positive effects of Thailand's pricing policies implemented over the past 16 years. The strategic interventions implemented by the Thai government have markedly enhanced the regulation and affordability of medicine prices. However, to sustain these achievements and ensure the viability of the local pharmaceutical industry, ongoing efforts and policy adaptations are essential. This study emphasises the critical need for continuous evaluation of these policies to respond effectively to evolving healthcare and economic conditions.
Collections
- Pharmacy Research [1357 items ]
Related items
Showing items related by title, author, creator and subject.
-
Relationship between pharmaceutical pricing strategies with price, availability, and affordability of cardiovascular disease medicines: Surveys in Qatar and Lebanon
Abdel Rida N.; Mohamed Ibrahim M.I.; Babar Z.U.D. ( BioMed Central Ltd. , 2019 , Article)Background: Cardiovascular diseases are the leading cause of death in Lebanon and Qatar. When lifestyle modifications prove insufficient, medication becomes a cornerstone in controlling such diseases and saving lives. ... -
The impact of Indonesian generic medicine pricing policy on medicine prices
Anggriani, Y.; Ibrahim, Mohamed Izham Mohamed; Suryawati, S.; Shafie, A.A. ( SAGE Publications Ltd , 2013 , Article)Introduction: The government of Indonesia has established a commitment to the provision of affordable medicines. The retail price of unbranded generic cannot exceed the maximum retail price set by the Ministry of Health. ... -
Medicines Pricing Policy and Strategies in Developing Countries: A Review
Abdel Rida N.; Ibrahim M.I.M. ( Elsevier Inc. , 2018 , Book chapter)Developing countries are still facing high out-of-pocket expenditure and low access to medicines despite the various efforts undertaken by international organizations to enhance the availability of essential medicines and ...